FDA Warns New Jersey Stem Cell Company – Pain News Network
Pain News Network |
FDA Warns New Jersey Stem Cell Company
Pain News Network The FDA issued new guidelines for stem cell therapy last November, a “risk-based approach” that critics say could slow the development of novel treatments for autoimmune diseases, cancer, diabetes, neuropathy, back pain and other illnesses. As PNN has … FDA Crackdown on Unapproved Stem Cell Therapies Starts with American CryoStem FDA warning on sale of unapproved stem cell product FDA Issues Warning Over Unapproved Stem Cell Therapies |
